PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.27%
Revenue decline while 3141.T shows 3.12% growth. Joel Greenblatt would examine competitive position erosion.
-1.69%
Cost reduction while 3141.T shows 2.40% growth. Joel Greenblatt would examine competitive advantage.
-4.56%
Gross profit decline while 3141.T shows 4.80% growth. Joel Greenblatt would examine competitive position.
-2.35%
Margin decline while 3141.T shows 1.62% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.15%
Other expenses growth while 3141.T reduces costs. John Neff would investigate differences.
2.21%
Operating expenses growth 1.25-1.5x 3141.T's 1.69%. Martin Whitman would scrutinize control.
-1.05%
Total costs reduction while 3141.T shows 2.20% growth. Joel Greenblatt would examine advantage.
-5.56%
Interest expense reduction while 3141.T shows 3.23% growth. Joel Greenblatt would examine advantage.
1.90%
D&A growth less than half of 3141.T's 6.68%. David Dodd would verify if efficiency is sustainable.
-22.98%
EBITDA decline while 3141.T shows 13.86% growth. Joel Greenblatt would examine position.
-21.20%
EBITDA margin decline while 3141.T shows 10.42% growth. Joel Greenblatt would examine position.
-29.63%
Operating income decline while 3141.T shows 26.01% growth. Joel Greenblatt would examine position.
-28.00%
Operating margin decline while 3141.T shows 22.19% growth. Joel Greenblatt would examine position.
41.98%
Other expenses growth while 3141.T reduces costs. John Neff would investigate differences.
-25.73%
Pre-tax income decline while 3141.T shows 18.54% growth. Joel Greenblatt would examine position.
-24.00%
Pre-tax margin decline while 3141.T shows 14.95% growth. Joel Greenblatt would examine position.
-24.55%
Tax expense reduction while 3141.T shows 19.57% growth. Joel Greenblatt would examine advantage.
-26.28%
Net income decline while 3141.T shows 17.94% growth. Joel Greenblatt would examine position.
-24.57%
Net margin decline while 3141.T shows 14.37% growth. Joel Greenblatt would examine position.
-26.27%
EPS decline while 3141.T shows 17.90% growth. Joel Greenblatt would examine position.
-26.27%
Diluted EPS decline while 3141.T shows 18.04% growth. Joel Greenblatt would examine position.
0.00%
Share count change of 0.00% while 3141.T is stable. Bruce Berkowitz would verify approach.
No Data
No Data available this quarter, please select a different quarter.